Home
Conditions
Neuroectodermal Tumors, Primitive

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

732 public trials 120 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Not yet recruiting

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

NCT07291102

Conditions: Glioma, Medulloblastoma, Neoplasms, +7 more
Locations: Children's of Alabama Birmingham, Alabama, United States

Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Not yet recruiting

Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

NCT06798532

Conditions: Ganglioneuroblastoma, Ganglioneuroma, Neoplasms, +11 more
Locations: CHU d'Amiens Amiens, France

CHU de Besançon Besançon, France

CHU de Bordeaux Bordeaux, France

CHU de Brest Brest, France

View all 27 locations

View Trial Details

Not yet recruiting

Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.

NCT07111117

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Institut Curie Paris, France

Hôpital Armand Trousseau Paris, France

Gustave Roussy Villejuif, France

View Trial Details

Not yet recruiting

GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.

NCT07090538

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital Beijing, China

Department of Pediatrics, The First Medical Center, Chinese PLA General Hospital Beijing, China

View Trial Details

Not yet recruiting

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

NCT06948994

Conditions: Autologous NK Cell, GD2 Antibody, Neoplasms, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas

NCT06323408

Conditions: Embryonal Tumor, Ependymoma, Glioma, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

NCT06873672

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +46 more
Locations: Guizhou Medical University Guiyang, Guizhou, China

View Trial Details

Not yet recruiting

In Vitro Models From Pediatric Brain Tumors

NCT06499636

Conditions: Ependymoma, Glioma, Glioma, Malignant, +9 more
Locations: Pediatric Oncology Unit- Fondazione Policlinico Gemelli IRCCS Roma, Rome, Italy

View Trial Details

Not yet recruiting

Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma

NCT06485908

Conditions: Ependymoma, Glioma, Medulloblastoma, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma

NCT06396481

Conditions: Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +19 more
Locations: Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Neuroectodermal Tumors, Primitive

Neuroectodermal Tumors, Primitive trial results

Related conditions